Arthur A Levin $RNA SEC Form 4 Insider Trading

Arthur A Levin has filed a total of 31 insider trades in $RNA since 2021. Their most recent trade was a sale of 1,872 shares, made on Jan 21, 2025. Their largest trade was a sale of 62,498 shares, made on Aug 15, 2022. We estimate that they now own 35,458 shares of $RNA, worth an estimated $1.2 million.

Insider Trading at $RNA

There have been a total of 97 insider trades reported at $RNA since 2021, with 800,000 shares purchased and 2.1 million shares sold. The most active insider traders in $RNA stock have been Sarah Boyce, Arthur A Levin, and Michael F Maclean. The most recent trade was a sale of 5,875 shares reported by Kathleen P. Gallagher (Chief Program Officer), made on Feb 03, 2025.

$RNA Executives and Stock Owners with Insider Trades

• Sarah Boyce, President and CEO

• Arthur A Levin, Chief Scientific Officer

• Michael F Maclean, Chief Financial Officer

• Teresa Mccarthy, Chief Human Resources Officer

• W. Michael Flanagan, CSTO

• Kathleen P. Gallagher, Chief Program Officer

• Steven George Hughes, Chief Medical Officer

• W. Michael Flanagan, Chief Scientific Officer

• Roderick Wong, MP and CIO

*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.